Compugen (CGEN) director awarded 10,000 options, 7,500 RSUs

Rhea-AI Filing Summary

Livnat Savitzky Kinneret reported acquisition or exercise transactions in this Form 4 filing.

Compugen director Livnat Savitzky Kinneret received equity awards on July 29, 2026, including options to purchase 10,000 Ordinary Shares at $2.26 per share expiring July 29, 2036, and 7,500 restricted stock units. Both awards vest 25% on October 1, 2027, with the remainder in 12 equal quarterly installments, subject to continued service. Following the RSU grant, her direct holdings of Ordinary Shares are reported as 20,850, and she also holds the 10,000-share option grant.

Insider Trade Summary

Net Buyer: 7,500 shares

Net Buy 2 txns

Insider Livnat Savitzky Kinneret

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Share Option (right to buy) F2	10,000	$0.00	$0.00
Grant/Award	Ordinary Shares F1	7,500	$0.00	$0.00

Holdings After Transaction: Share Option (right to buy) — 10,000 shares (Direct); Ordinary Shares — 20,850 shares (Direct)

Footnotes (2)

1. F1. Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
2. F2. This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

Key Figures

Option grant: 10,000 shares Exercise price: $2.26 per share Option expiration: 2036-07-29 +4 more

7 metrics

Option grant 10,000 shares Share Option (right to buy) granted on 2026-07-29

Exercise price $2.26 per share Conversion/exercise price for 10,000-share option grant

Option expiration 2036-07-29 Expiration date for the 10,000-share option grant

RSU award 7,500 units Restricted stock unit grant on 2026-07-29

Initial vesting date October 1, 2027 25% of RSUs and options vest on this date

Ordinary Shares held 20,850 shares Direct non-derivative holdings after RSU grant

Options held after grant 10,000 options Direct derivative holdings after option award

Key Terms

restricted stock unit ("RSU"), Share Option (right to buy), vesting, Ordinary Shares

4 terms

restricted stock unit ("RSU") financial

"Represents a restricted stock unit ("RSU") award."

Share Option (right to buy) financial

"Security titled Share Option (right to buy) was granted."

vesting financial

"The RSUs vest 25% on October 1, 2027."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Ordinary Shares financial

"Underlying security title is Ordinary Shares."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/30/2026 - 04:06 PM Accepted by SEC EDGAR 07/30/2026 - 04:05 PM Learn about SEC filing dates

FAQ

What insider transactions did CGEN's Livnat Savitzky Kinneret report?

Livnat Savitzky Kinneret reported receiving 10,000 share options at $2.26 per share and 7,500 RSUs on July 29, 2026. These awards are equity compensation from Compugen and increase her reported direct Ordinary Share holdings to 20,850, alongside the new option position.

What are the terms of the 10,000 Compugen (CGEN) share options?

The filing shows a grant of 10,000 options to buy Ordinary Shares at an exercise price of $2.26 per share, expiring on July 29, 2036. The options vest 25% on October 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments.

How do the 7,500 RSUs granted by CGEN to the director vest?

The 7,500 RSUs vest 25% on October 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments. Vesting is explicitly conditioned on the reporting person’s continued service to Compugen throughout the vesting period, as described in the footnote.

What are Livnat Savitzky Kinneret’s holdings after these CGEN grants?

After the reported transactions, direct holdings of Ordinary Shares are listed as 20,850. In addition, she holds a derivative position consisting of an option for 10,000 Ordinary Shares, reflecting the new option award granted on July 29, 2026.

Are the new CGEN equity awards subject to any service conditions?

Yes. Both the 7,500 RSUs and the 10,000-share option vesting schedules require the reporting person’s continued service to Compugen. If service terminates before vesting dates, unvested portions of these awards may not be earned, according to the disclosure language.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Livnat Savitzky Kinneret

(Last) (First) (Middle)

C/O COMPUGEN LTD.

26 HAROKMIM STREET

(Street)

HOLON 5885849

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
COMPUGEN LTD [ CGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol
[CGEN]

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/29/2026		A		7,500(1)	A	$0	20,850	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (right to buy)	$2.26	07/29/2026		A		10,000		(2)	07/29/2036	Ordinary Shares	10,000	$0	10,000	D

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

2. This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

	/s/ Kinneret Livnat Savitzky	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)